Population
Cancer survivors and patients diagnosed with cancer
Design
Review
Authors
Loading...
Requires CV monitoring in chemotherapy patients; leaves open need for prospective trials on risk mitigation.
Oncology agents can induce or exacerbate cardiovascular conditions, requiring careful monitoring and management of toxicities in cancer patients.
Frei et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: